{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T07:26:58Z","timestamp":1791617218186,"version":"4.3.4"},"reference-count":39,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Travel Medicine and Infectious Disease"],"published-print":{"date-parts":[[2016,9]]},"DOI":"10.1016\/j.tmaid.2016.05.010","type":"journal-article","created":{"date-parts":[[2016,5,27]],"date-time":"2016-05-27T22:51:41Z","timestamp":1464389501000},"page":"489-498","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Cost effectiveness of interferon-gamma release assay for tuberculosis screening using three months of rifapentine and isoniazid among long-term expatriates from low to high incidence countries"],"prefix":"10.1016","volume":"14","author":[{"given":"Akiko","family":"Kowada","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9228","key":"10.1016\/j.tmaid.2016.05.010_bib1","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/S0140-6736(00)02554-X","article-title":"Risk of infection with Mycobacterium tuberculosis in travellers to areas of high tuberculosis endemicity","volume":"356","author":"Cobelens","year":"2000","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.tmaid.2016.05.010_bib2","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1111\/j.1708-8305.2010.00424.x","article-title":"Systematic review and meta-analysis of TST conversion risk in deployed military and long-term civilian travelers","volume":"17","author":"Freeman","year":"2010","journal-title":"J Travel Med"},{"issue":"3","key":"10.1016\/j.tmaid.2016.05.010_bib3","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1086\/321882","article-title":"Association of tuberculin sensitivity in Dutch adults with history of travel to areas of with a high incidence of tuberculosis","volume":"33","author":"Cobelens","year":"2001","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.tmaid.2016.05.010_bib4","series-title":"Multidrug and extensively drug-resistant tuberculosis: 2010 global report on surveillance and response","author":"World Health Organization","year":"2010"},{"issue":"1","key":"10.1016\/j.tmaid.2016.05.010_bib5","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.jegh.2012.12.003","article-title":"Prevalence of pulmonary tuberculosis among expatriates subjected to medical visa screening in Abu Dhabi, United Arab Emirates","volume":"3","author":"Al Hosani","year":"2013","journal-title":"J Epidemiol Glob Health"},{"key":"10.1016\/j.tmaid.2016.05.010_bib6","doi-asserted-by":"crossref","first-page":"177","DOI":"10.7326\/0003-4819-149-3-200808050-00241","article-title":"Systematic review: T-cell-based assays for the diagnosis of latent tuberculosis infection: an update","volume":"149","author":"Pai","year":"2008","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.tmaid.2016.05.010_bib7","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1378\/chest.09-2350","article-title":"Evidence-based comparison of commercial interferon-gamma release assays for detecting active TB: a metaanalysis","volume":"137","author":"Diel","year":"2010","journal-title":"Chest"},{"issue":"23","key":"10.1016\/j.tmaid.2016.05.010_bib8","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1056\/NEJMoa1104875","article-title":"Three months of rifapentine and isoniazid for latent tuberculosis infection","volume":"365","author":"Sterling","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.tmaid.2016.05.010_bib9","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1186\/1471-2458-8-201","article-title":"Tuberculosis screening of travelers to higher-incidence countries: a cost-effectiveness analysis","volume":"8","author":"Tan","year":"2008","journal-title":"BMC Public Health"},{"issue":"1","key":"10.1016\/j.tmaid.2016.05.010_bib10","first-page":"38","article-title":"Risk of travelling to the country of origin for tuberculosis among immigrants living in a low-incidence country","volume":"15","author":"Kik","year":"2011","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1016\/j.tmaid.2016.05.010_bib11","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1378\/chest.128.1.116","article-title":"Isoniazid hepatotoxicity associated with treatment of latent tuberculosis infection: a 7-year evaluation from a public health tuberculosis clinic","volume":"128","author":"Fountain","year":"2005","journal-title":"Chest"},{"key":"10.1016\/j.tmaid.2016.05.010_bib12","first-page":"555","article-title":"Efficacy of various durations of isoniazid preventive therapy for tuberculosis: five years of follow-up in the IUAT trial","volume":"60","author":"International Union Against Tuberculosis Committee on Prophylaxis","year":"1982","journal-title":"Bull World Health Organ"},{"issue":"12","key":"10.1016\/j.tmaid.2016.05.010_bib13","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.5588\/ijtld.13.0423","article-title":"Cost-effectiveness of a 12-dose regimen for treating latent tuberculous infection in the United States","volume":"17","author":"Shepardson","year":"2013","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1016\/j.tmaid.2016.05.010_bib14","series-title":"Life tables, 2009","author":"Statistics Bureau, Ministry of Internal Affairs and Communications","year":"2010"},{"key":"10.1016\/j.tmaid.2016.05.010_bib15","first-page":"617","article-title":"Relapse rate of tuberculosis treated with standard regimen of chemotherapy","volume":"84","author":"Tuberculosis Research Committee","year":"2009","journal-title":"Kekkaku"},{"issue":"2","key":"10.1016\/j.tmaid.2016.05.010_bib16","doi-asserted-by":"crossref","first-page":"271","DOI":"10.4269\/ajtmh.13-0004","article-title":"A systematic review of the effectiveness of hospital- and ambulatory-based management of multidrug-resistant tuberculosis","volume":"89","author":"Bassili","year":"2013","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.tmaid.2016.05.010_bib17","series-title":"Tuberculosis surveillance","author":"Research Institute of Tuberculosis","year":"2009"},{"key":"10.1016\/j.tmaid.2016.05.010_bib18","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1183\/09031936.00115110","article-title":"Interferon-\u03b3 release assays for the diagnosis of latent Mycobacterium tuberculosis infection: a systematic review and meta-analysis","volume":"37","author":"Diel","year":"2011","journal-title":"Eur Respir J"},{"key":"10.1016\/j.tmaid.2016.05.010_bib19","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1378\/chest.115.5.1248","article-title":"The validity of medical history, classic symptoms, and chest radiographs in predicting pulmonary tuberculosis: derivation of a pulmonary tuberculosis prediction model","volume":"115","author":"Tattevin","year":"1999","journal-title":"Chest"},{"key":"10.1016\/j.tmaid.2016.05.010_bib20","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1378\/chest.109.2.420","article-title":"The validity of classic symptoms and chest radiographic configuration in predicting pulmonary tuberculosis","volume":"109","author":"Cohen","year":"1996","journal-title":"Chest"},{"key":"10.1016\/j.tmaid.2016.05.010_bib21","unstructured":"Ministry of Health, Labour and Welfare. BCG vaccination rate in Japan. [in Japanese]. http:\/\/www.mhlw.go.jp\/topics\/bcg\/other\/5.html [accessed 09.04.16]."},{"key":"10.1016\/j.tmaid.2016.05.010_bib22","series-title":"Medical insurance reimbursement table in Japan","author":"Igakutsushin-sya","year":"2010"},{"key":"10.1016\/j.tmaid.2016.05.010_bib23","unstructured":"Organisation for Economic Co-operation and Development. OECD.Stat. http:\/\/stats.oecd.org\/Index.aspx?datasetcode=SNA_TABLE4 [accessed 09.04.16]."},{"key":"10.1016\/j.tmaid.2016.05.010_bib24","unstructured":"Ministry of Health, Labor and Welfare. Basic survey on wage structure. [online]. Available from URL: http:\/\/www.mhlw.go.jp\/english\/database\/db-l\/index.html [accessed 09.04.16]."},{"issue":"11","key":"10.1016\/j.tmaid.2016.05.010_bib25","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1164\/rccm.200901-0153OC","article-title":"Costs and cost-effectiveness of four treatment regimens for latent tuberculosis infection","volume":"179","author":"Holland","year":"2009","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.tmaid.2016.05.010_bib26","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/1477-7525-7-14","article-title":"Measuring health-related quality of life in tuberculosis: a systematic review","volume":"7","author":"Guo","year":"2009","journal-title":"Health Qual Life Outcomes"},{"key":"10.1016\/j.tmaid.2016.05.010_bib27","doi-asserted-by":"crossref","first-page":"S102","DOI":"10.1177\/027298902237706","article-title":"Measurement of health preferences among patients with tuberculous infection and disease","volume":"22","author":"Dion","year":"2002","journal-title":"Med Decis Mak"},{"key":"10.1016\/j.tmaid.2016.05.010_bib28","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1023\/B:QURE.0000021320.89524.64","article-title":"Feasibility and reliability of health-related quality of life measurements among tuberculosis patients","volume":"13","author":"Dion","year":"2004","journal-title":"Qual Life Res"},{"issue":"4","key":"10.1016\/j.tmaid.2016.05.010_bib29","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/BF03256289","article-title":"Cost effectiveness of interferon-gamma release assay for tuberculosis contact screening in Japan","volume":"12","author":"Kowada","year":"2008","journal-title":"Mol Diagn Ther"},{"issue":"4","key":"10.1016\/j.tmaid.2016.05.010_bib30","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/BF03256378","article-title":"Cost effectiveness of interferon-gamma release assay versus chest X-ray for tuberculosis screening of BCG-vaccinated elderly populations","volume":"14","author":"Kowada","year":"2010","journal-title":"Mol Diagn Ther"},{"key":"10.1016\/j.tmaid.2016.05.010_bib31","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1016\/j.ejrad.2013.02.017","article-title":"Cost effectiveness of high resolution computed tomography with interferon-gamma release assay for tuberculosis contact investigation","volume":"82","author":"Kowada","year":"2013","journal-title":"Eur J Radiol"},{"issue":"2","key":"10.1016\/j.tmaid.2016.05.010_bib32","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.jhin.2014.10.002","article-title":"Cost-effectiveness of interferon-gamma release assay for systematic tuberculosis screening of healthcare workers in low-incidence countries","volume":"89","author":"Kowada","year":"2015","journal-title":"J Hosp Infect"},{"key":"10.1016\/j.tmaid.2016.05.010_bib33","doi-asserted-by":"crossref","first-page":"2224","DOI":"10.1017\/S0950268812002907","article-title":"Cost-effectiveness of interferon-gamma release assay for entry tuberculosis screening in prisons","volume":"141","author":"Kowada","year":"2013","journal-title":"Epidemiol Infect"},{"issue":"6","key":"10.1016\/j.tmaid.2016.05.010_bib34","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/BF03256394","article-title":"Cost effectiveness of interferon-gamma release assay for tuberculosis screening of rheumatoid arthritis patients prior to initiation of tumor necrosis factor-\u03b1 antagonist therapy","volume":"14","author":"Kowada","year":"2010","journal-title":"Mol Diagn Ther"},{"key":"10.1016\/j.tmaid.2016.05.010_bib35","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1093\/ndt\/gfs479","article-title":"Cost effectiveness of the interferon-\u03b3 release assay for tuberculosis screening of hemodialysis patients","volume":"28","author":"Kowada","year":"2013","journal-title":"Nephrol Dial Transpl"},{"issue":"1","key":"10.1016\/j.tmaid.2016.05.010_bib36","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.jinf.2013.08.009","article-title":"Cost effectiveness of interferon-\u03b3 release assay for TB screening of HIV positive pregnant women in low TB incidence countries","volume":"68","author":"Kowada","year":"2014","journal-title":"J Infect"},{"issue":"7","key":"10.1016\/j.tmaid.2016.05.010_bib37","doi-asserted-by":"crossref","first-page":"857","DOI":"10.5588\/ijtld.14.0518","article-title":"Cost-effectiveness of tobacco cessation support combined with tuberculosis screening among contacts who smoke","volume":"19","author":"Kowada","year":"2015","journal-title":"Int J Tuberc Lung Dis"},{"issue":"3","key":"10.1016\/j.tmaid.2016.05.010_bib38","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/s11908-011-0173-0","article-title":"The use of interferon-\u03b3 release assays for tuberculosis screening in international travelers","volume":"13","author":"Apers","year":"2011","journal-title":"Curr Infect Dis Rep"},{"key":"10.1016\/j.tmaid.2016.05.010_bib39","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1186\/1471-2334-14-515","article-title":"Screening travellers to high-endemic countries for infection with Mycobacterium tuberculosis using interferon gamma release assay: a prospective study","volume":"14","author":"Elfrink","year":"2014","journal-title":"BMC Infect Dis"}],"container-title":["Travel Medicine and Infectious Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1477893916300436?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1477893916300436?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T14:01:54Z","timestamp":1761487314000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1477893916300436"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9]]},"references-count":39,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2016,9]]}},"alternative-id":["S1477893916300436"],"URL":"https:\/\/doi.org\/10.1016\/j.tmaid.2016.05.010","relation":{},"ISSN":["1477-8939"],"issn-type":[{"value":"1477-8939","type":"print"}],"subject":[],"published":{"date-parts":[[2016,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cost effectiveness of interferon-gamma release assay for tuberculosis screening using three months of rifapentine and isoniazid among long-term expatriates from low to high incidence countries","name":"articletitle","label":"Article Title"},{"value":"Travel Medicine and Infectious Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tmaid.2016.05.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}